Cargando…
Clinical Performance of Aspergillus PCR for Testing Serum and Plasma: a Study by the European Aspergillus PCR Initiative
Aspergillus PCR testing of serum provides technical simplicity but with potentially reduced sensitivity compared to whole-blood testing. With diseases for which screening to exclude disease represents an optimal strategy, sensitivity is paramount. The associated analytical study confirmed that DNA c...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540904/ https://www.ncbi.nlm.nih.gov/pubmed/26085618 http://dx.doi.org/10.1128/JCM.00905-15 |
_version_ | 1782386307887005696 |
---|---|
author | White, P. Lewis Barnes, Rosemary A. Springer, Jan Klingspor, Lena Cuenca-Estrella, Manuel Morton, C. Oliver Lagrou, Katrien Bretagne, Stéphane Melchers, Willem J. G. Mengoli, Carlo Donnelly, J. Peter Heinz, Werner J. Loeffler, Juergen |
author_facet | White, P. Lewis Barnes, Rosemary A. Springer, Jan Klingspor, Lena Cuenca-Estrella, Manuel Morton, C. Oliver Lagrou, Katrien Bretagne, Stéphane Melchers, Willem J. G. Mengoli, Carlo Donnelly, J. Peter Heinz, Werner J. Loeffler, Juergen |
author_sort | White, P. Lewis |
collection | PubMed |
description | Aspergillus PCR testing of serum provides technical simplicity but with potentially reduced sensitivity compared to whole-blood testing. With diseases for which screening to exclude disease represents an optimal strategy, sensitivity is paramount. The associated analytical study confirmed that DNA concentrations were greater in plasma than those in serum. The aim of the current investigation was to confirm analytical findings by comparing the performance of Aspergillus PCR testing of plasma and serum in the clinical setting. Standardized Aspergillus PCR was performed on plasma and serum samples concurrently obtained from hematology patients in a multicenter retrospective anonymous case-control study, with cases diagnosed according to European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus definitions (19 proven/probable cases and 42 controls). Clinical performance and clinical utility (time to positivity) were calculated for both kinds of samples. The sensitivity and specificity for Aspergillus PCR when testing serum were 68.4% and 76.2%, respectively, and for plasma, they were 94.7% and 83.3%, respectively. Eighty-five percent of serum and plasma PCR results were concordant. On average, plasma PCR was positive 16.8 days before diagnosis and was the earliest indicator of infection in 13 cases, combined with other biomarkers in five cases. On average, serum PCR was positive 10.8 days before diagnosis and was the earliest indicator of infection in six cases, combined with other biomarkers in three cases. These results confirm the analytical finding that the sensitivity of Aspergillus PCR using plasma is superior to that using serum. PCR positivity occurs earlier when testing plasma and provides sufficient sensitivity for the screening of invasive aspergillosis while maintaining methodological simplicity. |
format | Online Article Text |
id | pubmed-4540904 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-45409042015-09-22 Clinical Performance of Aspergillus PCR for Testing Serum and Plasma: a Study by the European Aspergillus PCR Initiative White, P. Lewis Barnes, Rosemary A. Springer, Jan Klingspor, Lena Cuenca-Estrella, Manuel Morton, C. Oliver Lagrou, Katrien Bretagne, Stéphane Melchers, Willem J. G. Mengoli, Carlo Donnelly, J. Peter Heinz, Werner J. Loeffler, Juergen J Clin Microbiol Mycology Aspergillus PCR testing of serum provides technical simplicity but with potentially reduced sensitivity compared to whole-blood testing. With diseases for which screening to exclude disease represents an optimal strategy, sensitivity is paramount. The associated analytical study confirmed that DNA concentrations were greater in plasma than those in serum. The aim of the current investigation was to confirm analytical findings by comparing the performance of Aspergillus PCR testing of plasma and serum in the clinical setting. Standardized Aspergillus PCR was performed on plasma and serum samples concurrently obtained from hematology patients in a multicenter retrospective anonymous case-control study, with cases diagnosed according to European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus definitions (19 proven/probable cases and 42 controls). Clinical performance and clinical utility (time to positivity) were calculated for both kinds of samples. The sensitivity and specificity for Aspergillus PCR when testing serum were 68.4% and 76.2%, respectively, and for plasma, they were 94.7% and 83.3%, respectively. Eighty-five percent of serum and plasma PCR results were concordant. On average, plasma PCR was positive 16.8 days before diagnosis and was the earliest indicator of infection in 13 cases, combined with other biomarkers in five cases. On average, serum PCR was positive 10.8 days before diagnosis and was the earliest indicator of infection in six cases, combined with other biomarkers in three cases. These results confirm the analytical finding that the sensitivity of Aspergillus PCR using plasma is superior to that using serum. PCR positivity occurs earlier when testing plasma and provides sufficient sensitivity for the screening of invasive aspergillosis while maintaining methodological simplicity. American Society for Microbiology 2015-08-18 2015-09 /pmc/articles/PMC4540904/ /pubmed/26085618 http://dx.doi.org/10.1128/JCM.00905-15 Text en Copyright © 2015 White et al. http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported license (http://creativecommons.org/licenses/by-nc-sa/3.0/) , which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Mycology White, P. Lewis Barnes, Rosemary A. Springer, Jan Klingspor, Lena Cuenca-Estrella, Manuel Morton, C. Oliver Lagrou, Katrien Bretagne, Stéphane Melchers, Willem J. G. Mengoli, Carlo Donnelly, J. Peter Heinz, Werner J. Loeffler, Juergen Clinical Performance of Aspergillus PCR for Testing Serum and Plasma: a Study by the European Aspergillus PCR Initiative |
title | Clinical Performance of Aspergillus PCR for Testing Serum and Plasma: a Study by the European Aspergillus PCR Initiative |
title_full | Clinical Performance of Aspergillus PCR for Testing Serum and Plasma: a Study by the European Aspergillus PCR Initiative |
title_fullStr | Clinical Performance of Aspergillus PCR for Testing Serum and Plasma: a Study by the European Aspergillus PCR Initiative |
title_full_unstemmed | Clinical Performance of Aspergillus PCR for Testing Serum and Plasma: a Study by the European Aspergillus PCR Initiative |
title_short | Clinical Performance of Aspergillus PCR for Testing Serum and Plasma: a Study by the European Aspergillus PCR Initiative |
title_sort | clinical performance of aspergillus pcr for testing serum and plasma: a study by the european aspergillus pcr initiative |
topic | Mycology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540904/ https://www.ncbi.nlm.nih.gov/pubmed/26085618 http://dx.doi.org/10.1128/JCM.00905-15 |
work_keys_str_mv | AT whiteplewis clinicalperformanceofaspergilluspcrfortestingserumandplasmaastudybytheeuropeanaspergilluspcrinitiative AT barnesrosemarya clinicalperformanceofaspergilluspcrfortestingserumandplasmaastudybytheeuropeanaspergilluspcrinitiative AT springerjan clinicalperformanceofaspergilluspcrfortestingserumandplasmaastudybytheeuropeanaspergilluspcrinitiative AT klingsporlena clinicalperformanceofaspergilluspcrfortestingserumandplasmaastudybytheeuropeanaspergilluspcrinitiative AT cuencaestrellamanuel clinicalperformanceofaspergilluspcrfortestingserumandplasmaastudybytheeuropeanaspergilluspcrinitiative AT mortoncoliver clinicalperformanceofaspergilluspcrfortestingserumandplasmaastudybytheeuropeanaspergilluspcrinitiative AT lagroukatrien clinicalperformanceofaspergilluspcrfortestingserumandplasmaastudybytheeuropeanaspergilluspcrinitiative AT bretagnestephane clinicalperformanceofaspergilluspcrfortestingserumandplasmaastudybytheeuropeanaspergilluspcrinitiative AT melcherswillemjg clinicalperformanceofaspergilluspcrfortestingserumandplasmaastudybytheeuropeanaspergilluspcrinitiative AT mengolicarlo clinicalperformanceofaspergilluspcrfortestingserumandplasmaastudybytheeuropeanaspergilluspcrinitiative AT donnellyjpeter clinicalperformanceofaspergilluspcrfortestingserumandplasmaastudybytheeuropeanaspergilluspcrinitiative AT heinzwernerj clinicalperformanceofaspergilluspcrfortestingserumandplasmaastudybytheeuropeanaspergilluspcrinitiative AT loefflerjuergen clinicalperformanceofaspergilluspcrfortestingserumandplasmaastudybytheeuropeanaspergilluspcrinitiative |